Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc as compensation for lost sales of its generic version of...
Britain’s cost effectiveness body NICE have recommended Janssen Pharmaceutical’s Darzalex in combination with Velcade and dexamethasone (DVd), for...
Patients in the US will now be able to access another biosimilar version of Herceptin (trastuzumab) with the FDA approval of Pfizer’s Trazimera in...
Scotland’s cost effectiveness body has refused to fund Novartis’ CAR T therapy Kymriah for adult patients with lymphoma.
- FDA Commissioner Scott Gottlieb announces resignation - London man becomes second in world to be cured of HIV - Indian government set to colour...
Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with the...
Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra has been recommended by the EMA’s CHMP for...
Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of the most generous in Switzerland.
A man in Britain has become the second person to be ‘cured’ of HIV, after receiving a bone marrow transplant from a donor with natural resistance...
New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches